相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
HDAC-42; OSU-HDAC42
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
935881-37-1
- 规格:
10 mM * 1 mL/5 mg/10 mg/25 mg/50 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥1045.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥950.0 |
| 规格: | 10 mg | 产品价格: | ¥1600.0 |
| 规格: | 25 mg | 产品价格: | ¥2950.0 |
| 规格: | 50 mg | 产品价格: | ¥4450.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
AR-42
CAS No. : 935881-37-1
MCE 国际站:AR-42
产品活性:AR-42 (HDAC-42; OSU-HDAC42) 是一种口服生物有效的泛 HDAC 抑制剂 (IC50=16 nM)。AR-42 诱导生长抑制、细胞周期阻滞、凋亡和 caspases-3/7 活化。AR-42 促进 H3、H4 和 α-微管蛋白的高乙酰化,并上调 p21。AR-42 对多种人肿瘤细胞具有细胞毒性。
研究领域:Cell Cycle/DNA Damage | Epigenetics | Autophagy | Apoptosis
作用靶点:HDAC | Autophagy | Apoptosis
In Vitro: AR-42 (0.125-1 μM; 24 hours) inhibits cell proliferation in a dose-dependent manner, and the median IC50s for P815, C2, and BR cells are 0.65, 0.30, and 0.23 μM, respectively.
AR-42 (0.5 μM; 24 hours) induces cell-cycle arrest at G1 in the P815 cells and at G1/G2 in the C2 cells.
AR-42 (0.13-1 μM; 24 hours) causes a dose-dependent induction of apoptosis P815, C2, BR cells.
AR-42 (0.5-3 μM; 24 hours) induces hyperacetylation of histones H3 and H4 and α-tubulin.
In Vivo: AR-42 (10 mg/kg; tail vein injection; twice a week for three weeks) significantly inhibites tumor growth.
相关产品:Clinical Compound Library Plus | Bioactive Compound Library Plus | Apoptosis Compound Library | Cell Cycle/DNA Damage Compound Library | Epigenetics Compound Library | Histone Modification Research Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Autophagy Compound Library | Anti-Aging Compound Library | Oxygen Sensing Compound Library | Orally Active Compound Library | Anti-Pancreatic Cancer Compound Library | Rare Diseases Drug Library | Cell Death Library | MG-132 | Doxorubicin hydrochloride | Bafilomycin A1 | LY294002 | Tamoxifen | Paclitaxel | Y-27632 | Acetylcysteine | Angiotensin II human | 2-Deoxy-D-glucose | Staurosporine | SB-431542 | Actinomycin D | Deferoxamine mesylate | Bortezomib | 5-Fluorouracil | Trametinib | Sorafenib | Oxaliplatin | Gemcitabine | Temozolomide | Rotenone | Mdivi-1 | Elesclomol | Ruxolitinib | Decitabine | SP600125 | MK-2206 dihydrochloride | Etoposide | Trichostatin A
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验5.99 5.82 5.69 5.60 5.52 5.46 5.37 5.27 5.17 5.06 4.96 4.85 6 7 6.54 5.89 5.52 5.28 5.12 4.99 4.90 4.82 4.76 4.67 4.57 4.47 4.36 4.25 4.14 7 8 6.06 5.42 5.05 4.82 4.65 4.53 4.43 4.36 4.29 4.20 4.10 4.00 3.89 3.78 3.67 8 9 5.71 5.08 4.72 4.48
30分钟,以除去细胞有形成份。活活性荧光法测定步骤:AR活性测定的反应体系包括以下成分(最终浓度):67mmol/l的钠—钾磷酸缓冲液(pH 7.0),0.2mol/l 硫酸铵,0.1mmol/lNADPH,10mmol/l DL-甘油醛和红细胞溶血液10ul,总体积1.0ml.空白管以双蒸水代替DL—甘油醛。在37℃水浴反应5分钟后加0.3mol/l的NAOH2ml终止反应。充分混匀后60℃加热15分钟,破坏NADPH然后加11.8mol/l NAOH[内含0.1%H2O2) 3.0ml充分混匀
一、SP 法 1)脱蜡、水化;2)PBS 洗 2~3 次各 5 分钟;3)3% H2O2(80% 甲醇)滴加在 TMA 上,室温静置 10 分钟;4)PBS 洗 2~3 次各 5 分钟;5)抗原修复;6)PBS 洗 2~3 次各5分钟;7)滴加正常山羊血清封闭液,室温 20 分钟。甩去多余液体。8)滴加Ⅰ抗 50μl,室温静置 1 小时或者4℃过夜或者37℃1小时。9)4℃ 过夜后需在37℃复温45分钟。10)PBS 洗 3 次各 5 分钟;11)滴加 Ⅱ 抗 40~50 μl,室温
技术资料暂无技术资料 索取技术资料

















